表紙
市場調查報告書

聚合□鏈反應市場:全球行業趨勢,佔有率,規模,增長,機會,預測(2020-2025)

Polymerase Chain Reaction Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版商 IMARC Services Private Limited 商品編碼 953024
出版日期 內容資訊 英文 119 Pages
商品交期: 2-3個工作天內
價格
聚合□鏈反應市場:全球行業趨勢,佔有率,規模,增長,機會,預測(2020-2025) Polymerase Chain Reaction Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日期: 2020年07月18日內容資訊: 英文 119 Pages
簡介

2014年至2019年之間,全球聚合□鏈反應市場的複合年增長率約為7%。聚合□鏈反應(PCR)是指用於製造多個DNA片段副本的分子診斷技術。使用PCR機,以自動化的預編程程序控製樣品的溫度,以產生數百萬個DNA序列的精確副本。該技術可以識別和培養致病微生物,幫助檢測結核病,獲得性免疫缺陷綜合症(AIDS),感染和萊姆病。它在與生命科學相關的各種學科中找到了廣泛的應用,例如遺傳學,生物技術,分子生物學,藥物發現和臨床診斷。

各種傳染病和遺傳病的傳播是推動市場增長的重要因素之一。全球易患慢性病的老年人口的增長也推動了行業的增長。冠狀病毒疾病(COVID-19)的爆發已導致PCR技術的廣泛採用,以進行準確的診斷和早期發現感染。 PCR設備還有助於在整個過程中將污染風險和潛在的人為錯誤降至最低。此外,對個性化精準藥物的需求不斷增長,為市場帶來了積極的前景。這些藥物旨在提供使用PCR技術鑑定和開發的量身定制的療法。除了在生物技術領域的廣泛研究與開發(R&D)活動外,其他因素,包括臨床診斷應用的增加,有望進一步推動市場。展望未來,預計全球聚合□鏈反應市場在未來五年將繼續溫和增長。

該報告調查了全球聚合□鏈反應市場,市場概況,市場增長因素和阻礙因素的分析,市場規模過渡以及按產品,最終用戶,地區,競爭狀況,主要公司的預測我們提供系統的信息,例如您的個人資料,COVID-19的影響和市場機會。

目錄

第1章前言

第2章範圍和調查方法

第3章執行摘要

第4章簡介

第5章全球聚合□鏈反應市場

  • 市場概況
  • 市場表現
  • COVID-19的影響

第6章按產品細分的市場

  • 樂器
  • 試劑和消耗品
  • 軟件和服務

第7章按最終用戶細分的市場

  • 學術和研究機構
  • 臨床診斷實驗室和醫院
  • 製藥和生物技術公司
  • 其他

第8章按地區劃分的市場細分

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 國家市場

第9章SWOT分析

第10章價值鏈分析

第11章波特的五力分析

第12章價格分析

第13章競爭情況

  • 市場結構
  • 關鍵公司
  • 關鍵公司資料
    • Agilent Technologies Inc.
    • BD (Becton, Dickinson and Company)
    • BioMerieux (Institut Merieux SA)
    • Bio-RAD Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fluidigm Corporation
    • Merck KGaA
    • Perkinelmer Inc.
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
目錄
Product Code: SR1019L58_Report

The global polymerase chain reaction market grew at a CAGR of around 7% during 2014-2019. Polymerase chain reaction (PCR) refers to a molecular diagnostic technique that is used to make multiple copies of a segment of DNA. A PCR machine is used to manipulate the temperature of the sample in an automatic and pre-programmed procedure to generate millions of copies of DNA sequencing accurately. This technology identifies and cultures disease-causing microorganisms, which aid in the detection of tuberculosis, Acquired Immunodeficiency Syndrome (AIDS), infections and Lyme disease. Owing to this, it finds extensive applications across various life science-related fields, such as genetics, biotechnology, molecular biology, drug discovery and clinical diagnostics.

The increasing prevalence of various infectious diseases and genetic disorders is one of the key factors driving the growth of the market. The rising geriatric population across the globe, which is more prone to chronic medical ailments, is also driving the industry growth. The outbreak of the coronavirus disease (COVID-19) pandemic has further led to the widespread adoption of PCR technologies for accurate diagnosis and early detection of infections. PCR devices also aid in minimizing the risks of contamination and the chances of human errors in the entire process. Additionally, the increasing demand for personalized and precision medicines is also creating a positive outlook for the market. These medicines aim to provide tailor-made therapies, which are identified and developed using PCR technologies. Other factors, including the increasing application in clinical diagnostics, along with extensive research and development (R&D) activities in the field of biotechnology, are expected to drive the market further. Looking forward, IMARC Group expects the global polymerase chain reaction market to continue its moderate growth during the next five years.

Breakup by Product:

  • Instruments
  • Standard PCR Systems
  • Digital PCR Systems
  • Real-time PCR Systems
  • Reagents and Consumables
  • Software and Services

Breakup by End User:

  • Academic and Research Institutes
  • Clinical Diagnostics Labs and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., BD (Becton, Dickinson and Company), BioMerieux (Institut Merieux SA), Bio-RAD Laboratories Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Merck KGaA, Perkinelmer Inc., Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global polymerase chain reaction market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global polymerase chain reaction market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global polymerase chain reaction market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Polymerase Chain Reaction Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Standard PCR Systems
      • 6.1.2.1.1 Market Trends
      • 6.1.2.1.2 Market Forecast
      • 6.1.2.2 Digital PCR Systems
      • 6.1.2.2.1 Market Trends
      • 6.1.2.2.2 Market Forecast
      • 6.1.2.3 Real-Time PCR Systems
      • 6.1.2.3.1 Market Trends
      • 6.1.2.3.2 Market Forecast
    • 6.1.3 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Academic and Research Institutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Diagnostics Labs and Hospitals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pharmaceutical and Biotechnology Companies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BD (Becton, Dickinson and Company)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 BioMerieux (Institut Merieux SA)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-RAD Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Fluidigm Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Promega Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Takara Bio Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Polymerase Chain Reaction Market: Major Drivers and Challenges
  • Figure 2: Global: Polymerase Chain Reaction Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Polymerase Chain Reaction Market: Breakup by Product (in %), 2019
  • Figure 4: Global: Polymerase Chain Reaction Market: Breakup by End User (in %), 2019
  • Figure 5: Global: Polymerase Chain Reaction Market: Breakup by Region (in %), 2019
  • Figure 6: Global: Polymerase Chain Reaction Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 7: Global: Polymerase Chain Reaction (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 8: Global: Polymerase Chain Reaction (Instruments) Market: Breakup by Instrument Type (in %), 2019
  • Figure 9: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Polymerase Chain Reaction (Instruments- Standard PCR Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Polymerase Chain Reaction (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Polymerase Chain Reaction (Reagents and Consumables) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Polymerase Chain Reaction (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Polymerase Chain Reaction (Software and Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Polymerase Chain Reaction (Software and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Polymerase Chain Reaction (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Polymerase Chain Reaction (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: North America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: North America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: United States: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: United States: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Canada: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Canada: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Asia Pacific: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Asia Pacific: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: China: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: China: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Japan: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Japan: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: India: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: India: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: South Korea: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: South Korea: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Australia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Australia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Indonesia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Indonesia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Europe: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Europe: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Germany: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Germany: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: France: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: France: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: United Kingdom: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: United Kingdom: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: Italy: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: Italy: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: Spain: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Spain: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Russia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Russia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Latin America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Latin America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Brazil: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Brazil: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Mexico: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Mexico: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Middle East and Africa: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Middle East and Africa: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Global: Polymerase Chain Reaction Industry: SWOT Analysis
  • Figure 77: Global: Polymerase Chain Reaction Industry: Value Chain Analysis
  • Figure 78: Global: Polymerase Chain Reaction Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Polymerase Chain Reaction Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Polymerase Chain Reaction Market Forecast: Breakup by Product (in Million US$), 2020-2025
  • Table 3: Global: Polymerase Chain Reaction Market Forecast: Breakup by End User (in Million US$), 2020-2025
  • Table 4: Global: Polymerase Chain Reaction Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 5: Global: Polymerase Chain Reaction Market Structure
  • Table 6: Global: Polymerase Chain Reaction Market: Key Players